Location History:
- Shandong Province, CN (2017)
- Shandong, CN (2015 - 2018)
- Jinan, CN (2016 - 2019)
Company Filing History:
14 out of 28 
4 out of 4 
1 out of 1 Years Active: 2015-2019
Title: **Frank Wu: Innovator in Pharmaceutical Research**
Introduction
Frank Wu is a notable inventor based in Jinan, China, recognized for his significant contributions to pharmaceutical sciences. With a remarkable portfolio of 17 patents, he has dedicated his career to advancing the field of medicinal chemistry, particularly in the development of compounds that target critical biological pathways.
Latest Patents
Among Wu's latest inventions is a novel **tyrosine kinase inhibitor**. This compound, represented by Formula (I), or its pharmaceutically acceptable salts, esters, or solvates, presents a promising avenue for treating diseases associated with the overactivity of epidermal growth factor receptor (EGFR), including certain types of cancer. The invention details not only the method for the compound's preparation but also a pharmaceutical composition and a kit that incorporates this innovative compound. Additionally, another recent patent focuses on a **C-glycoside derivative**, described by a general formula (I) that identifies various components of the compound, highlighting its potential applications in medical treatments.
Career Highlights
Frank Wu has made substantial strides in the pharmaceutical industry through his work at Xuanzhu Pharma Co., Ltd. and Sihuan Pharmaceutical Holdings Group Ltd. His expertise in drug development has positioned him as a leading figure in creating therapeutic solutions that address critical medical needs.
Collaborations
Throughout his career, Wu has collaborated with talented professionals like Aichen Wang and Yan Zhang. These partnerships demonstrate the collective effort in driving innovations that can potentially transform patient care and treatment methodologies across the globe.
Conclusion
In conclusion, Frank Wu stands out as a prominent inventor in the field of pharmaceuticals. His dedication to research and development has led to breakthrough patents that enhance our understanding and treatment of diseases linked to tyrosine kinase activity. As he continues to innovate, his work promises to inspire future generations of researchers and inventors.